Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery

KANKO M., YAVUZ Ş., Duman C., Hosten T., Oner E., Berki T.

JOURNAL OF CARDIOTHORACIC SURGERY, vol.7, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7
  • Publication Date: 2012
  • Doi Number: 10.1186/1749-8090-7-3
  • Journal Name: JOURNAL OF CARDIOTHORACIC SURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Çanakkale Onsekiz Mart University Affiliated: Yes

Abstract

Background: Various types of markers have been used so far in order to reveal myocardial perfusion defect. However, these markers usually appear in the necrosis phase or in the late stage. Having been the focus of various investigations recently, ischemia-modified albumin (IMA) is helpful in establishing diagnosis in the early stages of ischemia, before necrosis develops.